Published in Clin Vaccine Immunol on May 14, 2014
Use of Genomic Tools to Improve Cattle Health in the Context of Infectious Diseases. Front Genet (2016) 0.75
NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41
Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. J Infect Dis (2005) 3.79
Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology (1984) 3.27
Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins. J Virol (2003) 1.98
Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature (1984) 1.90
Mycoplasma bovis: disease, diagnosis, and control. Res Vet Sci (2003) 1.87
Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus. J Gen Virol (1992) 1.73
A survey of virus infections of the respiratory tract of cattle and their association with disease. J Hyg (Lond) (1980) 1.49
Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies. J Clin Microbiol (1987) 1.35
Functions of alpha3beta1 integrin. Curr Opin Cell Biol (2000) 1.34
Bovine respiratory syncytial virus infection. Vet Res (2007) 1.32
A role for the alphavbeta3 integrin in the transmigration of monocytes. J Cell Biol (1998) 1.23
The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner. J Virol (2009) 1.20
Biochemical characterization of the respiratory syncytial virus P-P and P-N protein complexes and localization of the P protein oligomerization domain. J Gen Virol (2004) 1.18
The nine C-terminal amino acids of the respiratory syncytial virus protein P are necessary and sufficient for binding to ribonucleoprotein complexes in which six ribonucleotides are contacted per N protein protomer. J Gen Virol (2007) 1.15
Giving off mixed signals--distinct functions of alpha5beta1 and alphavbeta3 integrins in regulating cell behaviour. IUBMB Life (2009) 1.14
Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies. J Gen Virol (1992) 1.14
Tetraspanin CD151 mediates papillomavirus type 16 endocytosis. J Virol (2013) 1.11
A search for new microorganisms in calf pneumonia by the inoculation of gnotobiotic calves. Res Vet Sci (1982) 1.04
Characterization of salt-adapted secreted lignocellulolytic enzymes from the mangrove fungus Pestalotiopsis sp. Nat Commun (2013) 1.03
Antigenic heterogeneity of the attachment protein of bovine respiratory syncytial virus. J Gen Virol (1994) 1.02
Priming for local and systemic antibody memory responses to bovine respiratory syncytial virus: effect of amount of virus, virus replication, route of administration and maternal antibodies. Vet Immunol Immunopathol (1989) 1.02
Alloantibodies against MHC class I: a novel mechanism of neonatal pancytopenia linked to vaccination. J Immunol (2011) 0.99
CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha. Hepatology (2013) 0.93
Studies on the mechanism by which antigen-specific IgG suppresses primary antibody responses: evidence for epitope masking and decreased localization of antigen in the spleen. Scand J Immunol (2009) 0.92
Recognition of bovine respiratory syncytial virus proteins by bovine CD8+ T lymphocytes. Immunology (2003) 0.90
Evolution of bovine respiratory syncytial virus. J Virol (2000) 0.90
Sites of replication of bovine respiratory syncytial virus in naturally infected calves as determined by in situ hybridization. Vet Pathol (1996) 0.89
Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine. Vaccine (1992) 0.88
Bovine respiratory syncytial virus ISCOMs-Immunity, protection and safety in young conventional calves. Vaccine (2011) 0.88
A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus. Vaccine (2010) 0.84
Bovine respiratory syncytial virus ISCOMs--protection in the presence of maternal antibodies. Vaccine (2004) 0.84
Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus. PLoS One (2008) 0.84
Chimeric tymovirus-like particles displaying foot-and-mouth disease virus non-structural protein epitopes and its use for detection of FMDV-NSP antibodies. Vaccine (2007) 0.83
Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpesvirus-1 expressing the attachment glycoprotein of BRSV. J Gen Virol (1998) 0.83
Induction of antibody responses in the common mucosal immune system by respiratory syncytical virus immunostimulating complexes. Med Microbiol Immunol (1999) 0.82
Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV. Vaccine (1997) 0.82
DNA vaccination against respiratory syncytial virus in young calves. Vaccine (2005) 0.82
Exposure to pathogens and incidence of respiratory disease in young bulls on their arrival at fattening operations in France. Vet Rec (2009) 0.82
Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge. Vaccine (2007) 0.82
Passive protection of gnotobiotic calves using monoclonal antibodies directed at different epitopes on the fusion protein of bovine respiratory syncytial virus. J Infect Dis (1998) 0.81
Antigenically distinct G glycoproteins of BRSV strains share a high degree of genetic homogeneity. Virology (1997) 0.81
Experimental polyvalent ISCOMs subunit vaccine induces antibodies that neutralize human and bovine respiratory syncytial virus. Vaccine (1989) 0.80
T-cell populations responsive to bovine respiratory syncytial virus in seronegative calves. Vet Immunol Immunopathol (2002) 0.78
The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703. FEMS Immunol Med Microbiol (2005) 0.78
The RSV fusion receptor: not what everyone expected it to be. Microbes Infect (2012) 0.77
The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses. Clin Exp Immunol (1998) 0.77
Characterization of immunostimulating complexes (ISCOMS) of HIV-1. Viral Immunol (1990) 0.76
Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice. Vaccine (2013) 0.85
Fine mapping and characterization of the L-polymerase-binding domain of the respiratory syncytial virus phosphoprotein. J Virol (2015) 0.78
Investigation of the role played by cellobiose dehydrogenases from Podospora anserina during lignocellulose degradation. Appl Environ Microbiol (2016) 0.75